These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 16305513)
61. Quality control of the proteins associated with neurodegenerative diseases. Gao X; Hu H Acta Biochim Biophys Sin (Shanghai); 2008 Jul; 40(7):612-8. PubMed ID: 18604452 [TBL] [Abstract][Full Text] [Related]
62. The role of the ubiquitin proteasome system in Alzheimer's disease. Riederer BM; Leuba G; Vernay A; Riederer IM Exp Biol Med (Maywood); 2011 Mar; 236(3):268-76. PubMed ID: 21383047 [TBL] [Abstract][Full Text] [Related]
63. [Regulation of the protein degradation pathway by the ubiquitin family: its implication in neurodegenerative diseases]. Chiba T; Tanaka K Rinsho Shinkeigaku; 2005 Nov; 45(11):976-8. PubMed ID: 16447778 [TBL] [Abstract][Full Text] [Related]
64. Integration of multiple ubiquitin signals in proteasome regulation. Isasa M; Zuin A; Crosas B Methods Mol Biol; 2012; 910():337-70. PubMed ID: 22821603 [TBL] [Abstract][Full Text] [Related]
65. Alternative UPS drug targets upstream the 26S proteasome. Hjerpe R; Rodríguez MS Int J Biochem Cell Biol; 2008; 40(6-7):1126-40. PubMed ID: 18203645 [TBL] [Abstract][Full Text] [Related]
67. [Ubiquitin-proteasome system and sperm DNA repair: An update]. Zhang GW; Cai HC; Shang XJ Zhonghua Nan Ke Xue; 2016 Sep; 22(9):834-837. PubMed ID: 29071883 [TBL] [Abstract][Full Text] [Related]
68. Ubiquitin-proteasome system alterations in a striatal cell model of Huntington's disease. Hunter JM; Lesort M; Johnson GV J Neurosci Res; 2007 Jun; 85(8):1774-88. PubMed ID: 17455294 [TBL] [Abstract][Full Text] [Related]
69. Ubiquitin-26s proteasome system. New therapeutic implications (review). Sujashvili R Georgian Med News; 2008; (160-161):48-51. PubMed ID: 18711238 [TBL] [Abstract][Full Text] [Related]
70. Conformational diseases: an umbrella for various neurological disorders with an impaired ubiquitin-proteasome system. de Pril R; Fischer DF; van Leeuwen FW Neurobiol Aging; 2006 Apr; 27(4):515-23. PubMed ID: 16226348 [TBL] [Abstract][Full Text] [Related]
71. Proteomics of proteasome complexes and ubiquitinated proteins. Wang X; Guerrero C; Kaiser P; Huang L Expert Rev Proteomics; 2007 Oct; 4(5):649-65. PubMed ID: 17941820 [TBL] [Abstract][Full Text] [Related]
72. The ubiquitin proteasome system as a potential target for the treatment of neurodegenerative diseases. Ying Z; Wang H; Wang G Curr Pharm Des; 2013; 19(18):3305-14. PubMed ID: 23151138 [TBL] [Abstract][Full Text] [Related]
73. The vital link between the ubiquitin-proteasome pathway and DNA repair: impact on cancer therapy. Motegi A; Murakawa Y; Takeda S Cancer Lett; 2009 Sep; 283(1):1-9. PubMed ID: 19201084 [TBL] [Abstract][Full Text] [Related]
75. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies. Ciechanover A; Kwon YT Exp Mol Med; 2015 Mar; 47(3):e147. PubMed ID: 25766616 [TBL] [Abstract][Full Text] [Related]
76. Role of the proteasome in ethanol-induced liver pathology. Donohue TM; Cederbaum AI; French SW; Barve S; Gao B; Osna NA Alcohol Clin Exp Res; 2007 Sep; 31(9):1446-59. PubMed ID: 17760783 [TBL] [Abstract][Full Text] [Related]
77. [Motor neuron disease and ubiquitin-proteasome system dysfunction]. Niwa J; Sobue G Tanpakushitsu Kakusan Koso; 2006 Aug; 51(10 Suppl):1423-7. PubMed ID: 16922412 [No Abstract] [Full Text] [Related]
79. Emerging role of the ubiquitin-proteasome system as drug targets. Kar G; Keskin O; Fraternali F; Gursoy A Curr Pharm Des; 2013; 19(18):3175-89. PubMed ID: 23151131 [TBL] [Abstract][Full Text] [Related]